RAYMOND JAMES & ASSOCIATES - KARUNA THERAPEUTICS INC ownership

KARUNA THERAPEUTICS INC's ticker is KRTX and the CUSIP is 48576A100. A total of 259 filers reported holding KARUNA THERAPEUTICS INC in Q3 2022. The put-call ratio across all filers is 0.43 and the average weighting 1.0%.

Quarter-by-quarter ownership
RAYMOND JAMES & ASSOCIATES ownership history of KARUNA THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$405,985
-26.9%
2,401
-6.3%
0.00%
Q2 2023$555,570
-0.9%
2,562
-17.0%
0.00%
Q1 2023$560,723
-7.7%
3,087
-0.1%
0.00%
-100.0%
Q4 2022$607,185
-13.4%
3,090
-0.9%
0.00%0.0%
Q3 2022$701,000
+75.7%
3,117
-1.0%
0.00%
Q2 2022$399,000
-42.0%
3,150
-42.0%
0.00%
-100.0%
Q1 2022$688,000
-4.7%
5,428
-1.5%
0.00%0.0%
Q4 2021$722,000
+6.6%
5,509
-0.5%
0.00%0.0%
Q3 2021$677,000
+3.8%
5,538
-3.2%
0.00%0.0%
Q2 2021$652,000
-5.5%
5,720
-0.3%
0.00%0.0%
Q1 2021$690,000
+18.2%
5,738
-0.1%
0.00%0.0%
Q4 2020$584,000
+26.4%
5,745
-3.8%
0.00%0.0%
Q3 2020$462,000
-30.7%
5,974
-0.2%
0.00%0.0%
Q2 2020$667,000
+155.6%
5,987
+65.0%
0.00%
Q1 2020$261,000
-51.3%
3,629
-49.0%
0.00%
-100.0%
Q4 2019$536,0007,1100.00%
Other shareholders
KARUNA THERAPEUTICS INC shareholders Q3 2022
NameSharesValueWeighting ↓
Pivotal bioVenture Partners Investment Advisor LLC 797,008$134,766,08353.75%
Nan Fung Group Holdings Ltd 225,688$38,161,58430.90%
Sofinnova Investments, Inc. 1,381,149$233,538,48414.73%
First Light Asset Management, LLC 303,137$51,257,4354.87%
Altium Capital Management LP 34,000$5,749,0603.00%
DAFNA Capital Management LLC 52,873$8,940,2962.78%
Logos Global Management LP 115,000$19,445,3502.59%
GENERAL ATLANTIC, L.P. 986,710$166,842,7942.58%
MPM BioImpact LLC 53,210$8,997,2792.40%
Rock Springs Capital Management LP 505,433$85,463,6662.29%
View complete list of KARUNA THERAPEUTICS INC shareholders